CHICMAX (02145) signs a strategic cooperation framework agreement with KT-939 and Suzhou Open-up.

CHICMAX (02145) announced that recently the company's wholly-owned subsidiary, Suzhou Kai Tuo Pharmaceutical Co., Ltd., has entered into a strategic cooperation framework agreement with Kai Tuo Pharmaceuticals Limited (a company listed on the Hong Kong Stock Exchange (Stock Code: 9939)) in the field of cosmetics, with exclusive provisions related to the speedy commercialization of the whitening and spot-removing cosmetic raw material KT-939. According to the framework agreement, the company and Suzhou Kai Tuo will jointly promote the registration of KT-939 in China as a new ingredient in cosmetics and the registration of cosmetic products with KT-939 as the core ingredient in the field of cosmetics, along with conducting joint research and customization of functional ingredients, aiming to create a "top domestic whitening product" with industry influence based on KT-939. The company plans to utilize the development, registration, and application of KT-939 functional cosmetic raw materials to further enrich the company's product line layout, enhance the scientific research barriers of the company in front-line raw materials and product efficacy in cosmetics, and further strengthen the company's leadership position in the whitening and spot-removing cosmetic market.